| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007163101 |
| P356 | DOI | 10.1186/1748-717X-9-183 |
| P932 | PMC publication ID | 4152565 |
| P698 | PubMed publication ID | 25127719 |
| P2093 | author name string | Masao Murakami | |
| Takashi Daimon | |||
| Yusuke Demizu | |||
| Ryohei Sasaki | |||
| Nobukazu Fuwa | |||
| Osamu Fujii | |||
| Takashi Akagi | |||
| Kazuki Terashima | |||
| Yasue Niwa | |||
| Nor Shazrina Sulaiman | |||
| P2860 | cites work | Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial | Q31075401 |
| Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? | Q33386584 | ||
| Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer | Q34187098 | ||
| Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer | Q35050966 | ||
| Proton SBRT for medically inoperable stage I NSCLC. | Q35965653 | ||
| Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge? | Q36431587 | ||
| Modeling growth kinetics and statistical distribution of oligometastases | Q36431601 | ||
| Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments | Q37723610 | ||
| Stereotactic radiotherapy for pulmonary oligometastases: a systematic review | Q37755949 | ||
| Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer | Q37884875 | ||
| The use of proton-beam therapy in the treatment of non-small-cell lung cancer | Q38088273 | ||
| Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study | Q39675331 | ||
| Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty | Q39699179 | ||
| Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship | Q44016399 | ||
| Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer | Q46768027 | ||
| CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer : A prospective evaluation of 95 patients/118 lesions. | Q51227696 | ||
| Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. | Q53038622 | ||
| Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. | Q53363634 | ||
| Oligometastases. | Q55065168 | ||
| Oligometastases revisited | Q56773912 | ||
| Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: A dosimetric comparison with photon-based stereotactic body radiotherapy | Q59650958 | ||
| Carbon ion radiotherapy for stage I non-small cell lung cancer | Q73153881 | ||
| Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy | Q74816564 | ||
| Proton beams to replace photon beams in radical dose treatments | Q76347125 | ||
| Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) | Q80334723 | ||
| Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study | Q80587769 | ||
| Stereotactic body radiotherapy for oligometastatic lung tumors | Q80976956 | ||
| Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice | Q81600455 | ||
| High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer | Q83182085 | ||
| Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases | Q83412925 | ||
| Stereotactic body radiation therapy for lung metastases | Q84501695 | ||
| Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer | Q84714631 | ||
| Dose–Volume Comparison of Proton Radiotherapy and Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer | Q84791240 | ||
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 183 | |
| P577 | publication date | 2014-08-16 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors | |
| P478 | volume | 9 |
Search more.